BSEInsider Trading / SAST7 Oct 2026 · 7 Oct 2026, 10:32 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nandkumar Kadam
iSERA Lifesciences Ltd · 534920
✦ AI SummaryRelated Party
iSERA Lifesciences Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nandkumar Kadam.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern3/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
iSERA Lifesciences Ltd - 534920 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011